Dr. Steven M. Dubinett M.D.
Institution Name:
Total Awards:
1
Award Value:
$9,586,937
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | University of California, Los Angeles | A phase I trial of intratumoral administration of CCL21-gene modified dendritic cell (DC) combined with intravenous pembrolizumab for advanced NSCLC | $9,586,937 |
| Total: $9,586,937.00 |
